Therapy, Rehabilitation Show Promise for Long COVID Relief

Canadian researchers have found that cognitive behavioral therapy (CBT) and structured physical rehabilitation can significantly alleviate symptoms associated with long COVID, a condition affecting millions globally.

Therapy, Rehabilitation Show Promise for Long COVID Relief. Photo: tasnimnews.com

The study, conducted by McMaster University in Ontario, analyzed data from 24 trials involving 3,695 patients.

The research concluded that CBT likely reduces fatigue and enhances cognitive function in long COVID sufferers.

Additionally, intermittent aerobic exercise, performed three to five times weekly for four to six weeks, was shown to improve physical function and recovery.

Despite these promising findings, the researchers acknowledged challenges in implementing these treatments.

They noted that patients might question the safety and efficacy of these approaches, fearing the implication that long COVID is purely psychological rather than a physical condition.

Dr. Daniel Munblit, a paediatric long-term conditions expert at King’s College London who was not involved in the study, described the research as “top-quality” and commended its rigorous methodology.

“The work underscores the importance of addressing patient concerns and skepticism around CBT and rehabilitation, especially misconceptions about a psychological basis for long COVID,” Dr. Munblit said.

The study found no compelling evidence supporting alternative treatments such as certain medications, dietary supplements, or therapies like hyperbaric oxygen or transcranial stimulation.

Interventions examined included drugs like vortioxetine and leronlimab, as well as supplements such as coenzyme Q10 and synbiotics.

Long COVID continues to affect millions, with US officials estimating that one in ten individuals who contract the virus develop lingering symptoms.

In the UK, around two million people are reportedly living with the condition, including 112,000 children.
Symptoms range widely, from fatigue and breathlessness to muscle and joint pain.

Public awareness of long COVID has resurfaced following Violet Affleck’s revelation about a “post-viral infection” in 2019.

In July, she urged the LA County Board of Supervisors to reinstate mask mandates.

In the UK, however, the government has resisted reintroducing pandemic-era measures, relying instead on population immunity from vaccines and repeated infections.

While COVID surges still disrupt schools, healthcare, and public transport, officials no longer monitor the virus as they once did, reflecting a shift to pre-pandemic norms. (Tasnim News Agency)

YOU MAY ALSO LIKE

Time alone heightens ‘threat alert’ in teenagers – even when connecting online

Scientists say the findings might shed light on the link between loneliness and mental health conditions such as anxiety disorders, which are on the rise in young people.

Glaucoma drug shows promise against neurodegenerative diseases

A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in Alzheimer’s disease.

Magnetic field applied to both sides of brain shows rapid improvement for depression

A type of therapy that involves applying a magnetic field to both sides of the brain has been shown to be effective at rapidly treating depression in patients for whom standard treatments have been ineffective.

Harmful Pollutants from Common Personal Care Products

A new study from researchers at Switzerland’s École Polytechnique Fédérale de Lausanne (EPFL) has highlighted the potential health risks posed by the chemicals in popular personal care products, which can generate harmful pollutants when used indoors.

Alzheimer’s disease may damage the brain in two phases

Alzheimer’s disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping tools.

High cholesterol levels at a young age significant risk factor for atherosclerosis

Our risk of developing atherosclerosis – ‘furring’ of the arteries – can begin much earlier in life than was previously thought, highlighting the need to keep cholesterol levels low even when we are young, new research has discovered.